The overexpression of SOX9 was reported in some types of malignancies such as metastatic melanoma [15] non-small cell lung cancer [16], prostate cancer [17], and esophageal squamous cell carcinoma [12]. This evidence concerns the gene SOX9 and prostate cancer.